Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.49% | 50.12% | -15.12% | 27.86% | 15.84% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -100.00% | 60.41% | 1.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.29% | -- | -180.88% | -28.57% | 66.09% |
| Change in Net Operating Assets | -50.80% | 11.92% | 60.46% | -144.07% | -30.35% |
| Cash from Operations | -18.97% | 167.97% | 7.06% | 422.22% | -405.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -34.76% | -200.00% | -- | -- | -20.26% |
| Total Debt Repaid | 59.77% | -133.66% | -- | -- | 13.73% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 200.00% | -139.02% | 73.91% | 138.55% | -60.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.00% | -37.14% | 356.25% | 166.30% | -854.55% |